// App-Quantinova.ai

: Forty Percent of MDS Patients Wish They Received Red Blood Cell Transfusions at Higher Hemoglobin Thresholds Than They Currently Are: A Multinational Transfusion Audit

Researchers

Presenter

  • Rena Buckstein

Principal Investigators

  • Rebecca Starkman

  • Yulia Lin

  • Simon J. Stanworth

  • David Bowen

  • Lea Harrison

  • Sophie Wintrich

  • Jeannie Callum

Medical Centers

  • MDS Research Program, Sunnybrook Odette Cancer Center, Toronto, Canada

  • Vassar College, New York, NY

  • Department of Laboratory Medicine and Pathobiology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada

  • NHS Blood and Transplant, Oxford, United Kingdom

  • Department of Histopathology, Leeds Teaching Hospitals NHS Foundation Trust, Leeds, United Kingdom

  • MDS Foundation, Inc., Yardville, NJ

  • MDS UK Support Group, London, United Kingdom

Locations

  • Canada

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Aplastic anemia

  • Lymphomas

  • Anemia

Biomarkers

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • ISRCTN26088319

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved